1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      OR32-6 Pre-Surgical GH Levels Predict the Risk of Morphometric Vertebral Fracture, Which Is an Early and Frequent Event in the Natural History of Acromegaly

      abstract
      , MD, , MD, , MD, , MD, PhD, , MD, , MD
      Journal of the Endocrine Society
      Endocrine Society

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction. Acromegalic osteopathy is an emerging complication of the disease, characterized by increased bone turnover, deterioration in bone microarchitecture and high risk of vertebral fractures (VFs). However, the prediction of VFs in this clinical setting is still a matter of uncertainty, since the pathogenesis of acromegalic osteopathy is multifactorial and fractures may occur even in presence of normal bone mineral density. Purpose of the study. We aimed at evaluating the prevalence and determinants of VFs in a cohort of patients (pts) with acromegaly at hospital admission for transsphenoidal (TNS) surgery. Patients & Methods. We retrospectively enrolled 65 pts (34M/31F; age 50.4±11.7yrs) attending the Neurosurgery Unit before TNS surgery. All pts had a confirmed diagnosis of acromegaly (nadir GH during OGTT 75gr > 0.4 ng/mL and IGF-I above age-standardized upper normal limit), in whom all parameters of other pituitary axes (TSH, fT3, fT4, ACTH, cortisol, PRL, LH, FSH, E2/Testosterone) and a thoracic X-ray carried out for anesthesiological reasons were available. We performed a vertebral morphometric evaluation of the thoracic spine on X-ray images (MTRx), according to Genant grading. Data are presented as mean±SD; normally distributed continuous variables were analyzed with Student-t test; categorical data were analyzed with Fisher’s exact test. Results. Medical pre-treatment with SRLs was prescribed in 37 pts (56.9%, 19M/18F). At morphometric evaluation, 21 pts (32.3%, 11M/10F) presented with VFs (14 pts with mild VFs, 7 pts with moderate VFs). The fractured pts showed significantly higher GH levels when compared to non-fractured (20.1±28.0 ng/mL vs. 7.5±7.0 ng/mL; p<0.01). Conversely, no significant differences in thyroid, adrenal and gonadal parameters, as well as IGF-I and PRL levels between the two groups were observed. In multiple logistic regression analysis, GH was independently associated with the risk of any fracture (OR 1.09, 95%CI 1.01-1.17; p=0.03) and severity of VFs (1.04, 95%CI 1.01-1.07; p=0.03). Conclusions. For the first time, we observed that VFs are a very frequent, early and sometimes severe complication of acromegaly. Our findings also showed that pre-surgical GH levels were able to predict the risk and the severity of VFs at MTRx in patients with acromegaly.

          Related collections

          Author and article information

          Journal
          J Endocr Soc
          J Endocr Soc
          jes
          Journal of the Endocrine Society
          Endocrine Society (Washington, DC )
          2472-1972
          15 April 2019
          30 April 2019
          : 3
          : Suppl 1 , ENDO 2019 Abstracts - 101st Annual Meeting of the Endocrine Society – March 23 – 26th, 2019 – New Orleans, Louisiana
          : OR32-6
          Affiliations
          [_1]Chair of Endocrinology, Università Vita-Salute San Raffaele, Milan, , Italy
          [_2]Chair of Endocrinology, Chair of Endocrinology, Università Vita-Salute San Raffaele, Milan, , Italy
          [_3]Endocrinology & Metabolism, Chair of Endocrinology, Università Vita-Salute San Raffaele, Milan, , Italy
          [_4]Chair of Neurosurgery, Università Vita-Salute San Raffaele, Milan, , Italy
          Article
          js.2019-OR32-6
          10.1210/js.2019-OR32-6
          6554910
          52796896-3199-4999-8a9b-c0dc8e4adbd9
          Copyright © 2019 Endocrine Society

          This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/).

          History
          Categories
          Neuroendocrinology and Pituitary
          Pituitary Disease Markers and Case Series

          Comments

          Comment on this article